300677.SHE Shandong Intco Medical Products Co Ltd
- Market cap
- CNY 28.9B
- P/E
- 98.0x
- P/B
- 1.54x
- ROE
- 1.5%
- Dividend yield
- 1.46%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300677.SHE undervalued?
Graham number300677.SHE trades 159.1% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Shandong Intco Medical Products Co Ltd fundamental analysis
No fundamental analysis for Shandong Intco Medical Products Co Ltd yet.
Shandong Intco Medical Products Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Shandong Intco Medical Products Co Ltd
Intco Medical Technology Co., Ltd. engages in the research and development, production, and marketing of medical consumables, rehabilitation equipment, and physiotherapy care for medical and elderly care institutions, household daily use, and other related industries in China and internationally. The company offers disposable gloves, gowns, apparel, face masks, diaper, pad, wipes, non-woven sundries, PE products, and hand hygiene; wheelchair, scooter, rollator, lift, and oth…
Full company profileShandong Intco Medical Products Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Shandong Intco Medical Products Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 1.18B | 1.75B | 1.89B | 2.08B | 13.8B | 16.2B | 6.61B | 6.92B | 9.52B | 9.93B | 14.2B |
| Gross Profit | 290M | 434M | 467M | 521M | 9.55B | 9.97B | 838M | 942M | 2.18B | 2.39B | 4.91B |
| Operating Income | 100M | 168M | 204M | 202M | 8.37B | 8.69B | 707M | 439M | 1.68B | 974M | 3.18B |
| EBITDA | 146M | 266M | 266M | 309M | 8.76B | 8.95B | 557M | 557M | 1.74B | 2.57B | 1.11B |
| Net Income | 86.0M | 145M | 179M | 178M | 7.01B | 7.43B | 629M | 383M | 1.47B | 1.01B | 283M |
| EPS | 0.22 | 0.32 | 0.34 | 0.33 | 19 | 11 | 0.95 | 0.58 | 2.26 | 1.54 | 0.43 |
| Balance Sheet | |||||||||||
| Total Assets | 1.16B | 1.66B | 2.42B | 2.99B | 12.9B | 20.6B | 21.5B | 27.1B | 34.6B | 40.1B | 41.0B |
| Total Liabilities | 628M | 571M | 1.15B | 1.49B | 3.49B | 4.50B | 5.43B | 10.8B | 16.9B | 21.5B | 22.3B |
| Shareholders' Equity | 535M | 1.09B | 1.27B | 1.48B | 9.34B | 15.9B | 15.8B | 16.0B | 17.4B | 18.3B | 18.3B |
| Cash & Short-term Investments | 106M | 314M | 858M | 872M | 6.39B | 8.28B | 6.66B | 12.5B | 18.8B | 5.95B | 5.43B |
| Total Debt | 360M | 251M | 816M | 998M | 252M | 255M | 1.55B | 7.11B | 12.8B | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 80.6M | 247M | 186M | 330M | 8.59B | 8.68B | 1.07B | 502M | 1.08B | 1.89B | - |
| Capital Expenditure | 215M | 212M | 309M | 537M | 2.89B | 5.44B | 1.72B | 1.44B | 1.79B | 2.57B | 1.43B |
| Free Cash Flow | -137M | 35.3M | -123M | -207M | 5.70B | 3.24B | -650M | -936M | -710M | -690M | 1.93B |
| Ratios | |||||||||||
| ROE | 16.1% | 13.3% | 14.1% | 12.1% | 75.0% | 46.8% | 4.0% | 2.4% | 8.4% | 5.5% | 1.5% |
| ROA | 7.4% | 8.7% | 7.4% | 6.0% | 54.2% | 36.0% | 2.9% | 1.4% | 4.2% | 2.5% | 0.7% |
| Net Profit Margin | 7.3% | 8.3% | 9.5% | 8.6% | 50.6% | 45.8% | 9.5% | 5.5% | 15.4% | 10.2% | 2.0% |
| Debt to Equity | 0.67x | 0.23x | 0.64x | 0.68x | 0.03x | 0.02x | 0.10x | 0.44x | 0.74x | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Shandong Intco Medical Products Co Ltd dividends
- Dividend yield
- 1.46%
- Forward dividend
- 0.20 CNY
- Payout ratio
- 41.8%
- Ex-dividend date
- Sep 4, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 422M | 0.64 | 41.8% |
| 2024 | CNY 338M | 0.52 | 23.1% |
| 2023 | CNY 185M | 0.28 | 48.3% |
| 2022 | CNY 412M | 0.62 | 65.5% |
| 2021 | CNY 1.06B | 1.56 | 14.2% |
| 2020 | CNY 144M | 0.39 | 2.1% |
| 2019 | CNY 29.7M | 0.05 | 16.7% |
| 2018 | CNY 28.2M | 0.05 | 15.7% |
| 2017 | CNY 14.8M | 0.03 | 10.2% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1.2:1 on Jun 13, 2022.
Who owns Shandong Intco Medical Products Co Ltd
- Insiders 35.72%
- Institutions 16.98%
- Public & others 47.31%
- Shares outstanding 655M
- Free float 416M
Shandong Intco Medical Products Co Ltd company profile
- Company name
- Shandong Intco Medical Products Co Ltd
- Ticker
- 300677.SHE
- ISIN
- CNE100003456
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Employees
- 12,941
- Fiscal year end
- December
- Address
- No.18, Qingtian Road, Zibo, China, 255414
- Phone
- 86 53 3609 8666
- Website
- intcomedical.com.cn
About Shandong Intco Medical Products Co Ltd
Intco Medical Technology Co., Ltd. engages in the research and development, production, and marketing of medical consumables, rehabilitation equipment, and physiotherapy care for medical and elderly care institutions, household daily use, and other related industries in China and internationally. The company offers disposable gloves, gowns, apparel, face masks, diaper, pad, wipes, non-woven sundries, PE products, and hand hygiene; wheelchair, scooter, rollator, lift, and others; physical therapy hot and cold therapy, sport and outdoor, pet products, patient monitoring, and electrosurgery. It also provides ECG electrode, such as monitoring ECG, stress test and holter, diagnostic ECG, pre-wired neonatal, repositionable, tens, off-set ECG, and defibrillation electrode; grounding pad, electrosurgical pencil, and feminine care. The company was formerly known as Intco Medical Technology Co., Ltd. and changed its name to Intco Medical Technology Co., Ltd. in January 2020. Intco Medical Technology Co., Ltd. was founded in 2009 and is headquartered in Zibo, China.
Shandong Intco Medical Products Co Ltd management
4- Ms. Qiong ChenGM & Director · born 1982
- Ms. Feng JieCFO & Secretary · born 1985
- Mr. Hai Sheng YuDeputy GM & Non-Independent Director · born 1976
- Yufa JiaoHead of Accounting Department